November 2008 - Page 70 of 76

MondayNov 03, 2008 4:19 am

Arcade Acquisition Corporation (OTC BB: ACDQ)

Arcade Acquisition Corporation (OTC BB: ACDQ) is a private investment partnership that invests in middle-market leveraged buy-out and recapitalization transactions. Arcade gained national recognition for prior investments such as American Cellular Corporation and BoxUSA Inc. Led by their three principals John Chapman, Jonathan Furer and Muhit Rahman, Arcade Acquisition is well-placed for the future. For further information, visit the company website at: www.arcadepartners.com.

MondayNov 03, 2008 4:19 am

Neurobiological Technologies, Inc. (NASDAQ: NTII)

Neurobiological Technologies, Inc. (NASDAQ: NTII), a biotechnology company, has their focus on acquiring and developing central nervous system (CNS) related drug candidates. The company strategically in-licenses late-stage CNS agents and then pursues regulatory approval and commercialization. Neurobiological’s goal as a company is to develop and market drug candidates in the United States, Europe and Asia while possibly seeking partnerships with pharmaceutical and biotechnology companies. For further information, visit the Company's web site at www.ntii.com.

MondayNov 03, 2008 4:18 am

Neuralstem, Inc. (AMEX: CUR)

Neuralstem, Inc. (AMEX: CUR), a publicly traded biotherapeutics company, is focused on applying stem cell research and its patented human neural stem cell technology to treat diseases of the central nervous system. The company’s patent-protected technology allows them to produce mature, commercial quantities of neural stem cells that have the capability to control the differentiation of the cells into physiologically relevant human neurons and glia. For further information, visit the Company's web site at www.neuralstem.com.

MondayNov 03, 2008 4:18 am

NetSol Technologies, Inc. (NASDAQ: NGNM)

NetSol Technologies, Inc. (NASDAQ: NTWK) is a leading global IT solutions and services provider catering to clients all over the world. While catering to the private and public sector, NetSol made national news when it was announced that Najeeb Ghauri, , chairman and chief executive officer, and Mitch Van Wye, chief operating officer, will present at the Rodman & Renshaw Annual Global Investment Conference in New York City on Monday, November 10, 2008 at the New York Palace Hotel. For further information, visit the company website at: www.netsoltek.com.

MondayNov 03, 2008 4:17 am

Neoprobe Corporation (OTC BB: NGNM)

Neoprobe Corporation (OTC BB: NEOP) has focused their efforts on developing and commercializing novel biomedical products that address the critical intraoperative, diagnostic and therapeutic treatment needs of patients and physicians. The company’s main area of dedication is on improving cancer surgery outcomes by utilizing their market-leading gamma detection devices in conjunction with radiopharmaceutical agents.

MondayNov 03, 2008 4:16 am

NeoGenomics, Inc. (OTC BB: NGNM)

NeoGenomics, Inc. (OTC BB: NGNM) is known as the only publicly-traded pure-play laboratory testing service provider that has a specific focus on high revenue cancer genetics testing. The combination of advances in technology and genetic research, with the complete sequencing of the human genome, sophisticated new scientific testing tools to diagnose and treat diseases have been made possible. The company’s two facilities in Ft. Myers, Fla., and other facilities in Nashville, Tenn. and Irvine, Calif provide state of the art genetic testing. For further information, visit the Company's web site at www.neogenomics.org.

MondayNov 03, 2008 4:16 am

Aradigm Corporation (OTC BB: ARDM)

Aradigm Corporation (OTC BB: ARDM), an emerging specialty pharmaceutical company, is committed to developing and commercializing a portfolio of drugs designed to treat severe respiratory diseases. With its clinical expertise, targeted development efforts, and strength of a well accomplished leadership team, the company is poised to capitalize on niche opportunities for new and improved products used in the treatment of severe respiratory disease. For further information, visit the Company's web site at www.aradigm.com.

MondayNov 03, 2008 4:16 am

NAPCO Security Systems, Inc. (NASDAQ:NSSC)

NAPCO Security Systems, Inc. (NASDAQ:NSSC) is a leading manufacturer of a wide array of security products, developing advanced technologies for intrusion, fire, video, wireless, access control and door locking systems. With headquarters in New York, the company has branched into the international market by opening offices in the United Kingdom, the Caribbean, and Dubai. While many of NAPCO’s products have gained national attention, their Alarm Lock Division is the company’s fastest growing product and has been a leader in the marketplace since 1987. For further info, visit the company website at: www.napcosecurity.com.

MondayNov 03, 2008 4:15 am

Antigenics, Inc. (NASDAQ: AGEN)

Antigenics, Inc. (NASDAQ: AGEN) is focused on enhancing and extending the lives of patients by developing superior health care products for a broad array of cancers, infectious diseases and autoimmune disorders. Earlier this year, the company’s patient-specific cancer vaccine Oncophage ® (vitespen) was approved in Russia for the treatment of kidney cancer patients at intermediate risk for disease recurrence. Antigenics is now committed to exploring other major geographical territories for regulatory approval of Oncophage. For further information, visit the Company's web site at www.antigenics.com.

MondayNov 03, 2008 4:15 am

Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS)

Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS), a clinical-stage biopharmaceutical company, is focused on improving patient care by developing novel medicines in the areas of hepatitis C and oncology. The Company is developing two potentially complementary agents for the treatment of chronic hepatitis C: ANA598, a non-nucleoside polymerase inhibitor; and ANA773, an oral TLR7 agonist prodrug. For further information, visit the Company's web site at www.anadyspharma.com.

Site Search

Company Search

Month: November 2008

Arcade Acquisition Corporation (OTC BB: ACDQ)

Neurobiological Technologies, Inc. (NASDAQ: NTII)

Neuralstem, Inc. (AMEX: CUR)

NetSol Technologies, Inc. (NASDAQ: NGNM)

Neoprobe Corporation (OTC BB: NGNM)

NeoGenomics, Inc. (OTC BB: NGNM)

Aradigm Corporation (OTC BB: ARDM)

NAPCO Security Systems, Inc. (NASDAQ:NSSC)

Antigenics, Inc. (NASDAQ: AGEN)

Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS)

Market Basics

Newsletter Publishers

Public Companies